U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514962) titled 'Minimally Invasive Coronary Artery Bypass Supported by Cangrelor' on March 25.
Brief Summary: The purpose of this study is to find out whether it is safe and practical to perform MIDCAB surgery (a minimally invasive heart bypass procedure) while patients receive a continuous cangrelor infusion during the operation. Cangrelor is a medicine that helps prevent blood clots and works quickly through a vein drip.
The study compares patients receiving cangrelor during surgery to patients who had the same surgery in the past while on aspirin, with or without cangrelor given beforehand.
Study Question: Can MIDCAB surgery be safely performe...